investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Targeting Chromatin Modifications in Leukemia with Trisomy 21

Andrew A Lane

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

No posts

Related projects

Irving L. Weissman

HSC Diversity, in aging, ontogeny, and transformation

Leukaemia

Jerald Patrick Radich

The Genetics of Post-Transplant Relapse in Myeloid Malignancy

Leukaemia

Pathology

Julie Aurore Losman

The Role of EglN1 and HIF in Normal Hematopoiesis and in Leukemia

Leukaemia

Thomas Waldmann

IL-2/IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design

Leukaemia

Pathology Hematology and hematologic malignancies

James J-D Hsieh

Molecular Mechanisms of Impaired DAN Damage Response in Leukemia Pathogenesis

Leukaemia

Pathology

Alex Kentsis

Aberrant activation of HGF/MET signaling as a therapeutic target in AML

Leukaemia

Robert G Roeder

Function and targeting of a stable transcription factor complex in leukemia

Leukaemia

Dong-Er Zhang

Molecular Mechanism of Leukemogenesis Involving AML1-ETO

Leukaemia

Pathology Hematology and hematologic malignancies

Monica J Justice

The Pluripotency Regulator Prdm14 Initiates Cancer by Epigenetic Mechanisms

Leukaemia

Pathology Hematology and hematologic malignancies